Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Zheng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3381-230X; OpenAlex author ID A5101820299. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 1, last author 0)
Trials
1
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2008: 1 trial · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Editorial expression of concern: Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/… Co-author DOI 10.1186/s12943-025-02326-6↗
  2. Laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic ductal adenocarcinoma: protocol of a mul… First author DOI 10.21203/rs.3.rs-3993645/v1↗
  3. Exploration of the lymphadenectomy strategy for elderly pancreatic ductal adenocarcinoma patients undergoing curative-intent resection. Co-author PMID 37293173↗
  4. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Co-author DOI 10.1186/1476-4598-13-130↗

Trials 1

  1. Oncologic Safety and Lymphadenectomy in Parenchyma-Sparing Resection for SPN Study chair NCT07592663↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kun-Ling Xie · 2 shared papers, 2014–2025 · strength 0.25
  2. Zekuan Xu · 2 shared papers, 2014–2025 · strength 0.25
  3. Wentao Gao · 2 shared papers, 2014–2025 · strength 0.25
  4. Yunpeng Peng · 2 shared papers, 2014–2025 · strength 0.25
  5. Jie Tang · 2 shared papers, 2014–2025 · strength 0.25
  6. Zhuyin Qian · 2 shared papers, 2014–2025 · strength 0.25
  7. Junli Wu · 2 shared papers, 2014–2025 · strength 0.25
  8. Kuirong Jiang · 2 shared papers, 2014–2025 · strength 0.25
  9. Xianjun Yu · 1 shared paper, 1 shared trial, 2008–2024 · strength 0.22
  10. Jingjing Zhang · 1 shared paper, 2025 · strength 0.21
  11. Yi Miao · 1 shared paper, 2025 · strength 0.21
  12. Yingtai Chen · 1 shared paper, 2023 · strength 0.19
  13. Dongbing Zhao · 1 shared paper, 2023 · strength 0.19
  14. Heli Gao · 1 shared paper, 2024 · strength 0.18
  15. Xinran Liu · 1 shared paper, 2024 · strength 0.18
  16. Haidi Chen · 1 shared paper, 2024 · strength 0.18
  17. Wenjie Tang · 1 shared paper, 2024 · strength 0.18
  18. Mengqi Liu · 1 shared paper, 2024 · strength 0.18
  19. Qifeng Zhuo · 1 shared paper, 2024 · strength 0.18
  20. Wenyan Xu · 1 shared paper, 2024 · strength 0.18
  21. Wensheng Liu · 1 shared paper, 2024 · strength 0.18
  22. Chenjie Zhou · 1 shared paper, 2024 · strength 0.18
  23. Xiaowu Xu · 1 shared paper, 2024 · strength 0.18
  24. Shunrong Ji · 1 shared paper, 2024 · strength 0.18
  25. Xiaowu Xu · 1 shared trial, 2008 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.